Skip to main content
. 2022 Oct 29;14(21):5336. doi: 10.3390/cancers14215336

Table 2.

Combinatorial indices (CI) as determined by isobole testing at the IC30, IC50 and IC70 values for paclitaxel or sabizabulin when paired with lapatinib in JIMT and AU565 HER2+ cell lines. Results are representative of three biological replicate isobole assays. Values < 1.0 indicate synergistic drug action, while values of approximating 1.0 are indicative of an additive effect, whereas values > 1.0 suggest antagonism.

JIMT AU565
Lapatinib
+ 3 nM Paclitaxel
Lapatinib +
30 nM Sabizabulin
Lapatinib +
2 nM Paclitaxel
Lapatinib +
10 nM Sabizabulin
IC30 1.35 0.48 1.49 0.97
IC50 1.17 0.22 1.49 0.89
IC70 1.14 1.02 1.53 0.88